Copper Compounds in Cancer Chemotherapy
Keywords: Cancer Chemotherapy; Carboplatino; Casiopeína II-gly; Casiopeína III-ia; Casiopeínas®; Copper compounds; Cu (II) thiosemicarbazidecomplexes; Cytotoxicity; DNA targeting; Isatin-Schiff base copper (II); L-amino acidate; Leukemia L1210; Lobaplatino; Melanoma B16; Menkes disease (MD); Nedaplatino; Oxalilplatino; Pt clinical drugs; Structure-Activity Relationships; Wilson disease (WD); antineoplastic drug; antiproliferative activity; antitumor activi-ties; antitumor agents; ascorbate oxidase; benzimidazole; bipyridine complexes; cardiovascular toxicity; cell proliferation; cisplatin (CDDP); cisplatin therapy; copper Casiopeinas; copper-based antitumor agents; copper-biological molecules; cytostatic; diimine ligand; drugs; genotoxic; genotoxic activity; geometries; glutathione depletion; hematological effects; hemolytic anemia; imidazole; low hydrosolubility; medicinal inorganic chemistry; medulloblastoma; metal-ligand combination; mixed-ligand complexes; murine glioma; organic based drugs; phenanthroline; phenanthroline basicity; phenanthrolines; platinum-based drugs; recognition of target sites; therapeutic potential; thiosemicarbazone complexes; tumor cell growth; tyrosinase
Document Type: Research Article
Publication date: 2010-11-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.